List view / Grid view
5 December 2014 | By Evgen Pharma
Evgen Pharma plc, a clinical stage drug development company focused on the treatment of cancer and neurological conditions, announces its intention to join the AIM market of the London Stock Exchange by way of a Placing to raise up to £20 million...
4 December 2014 | By Deloitte
In a written ministerial statement issued, the Financial Secretary to the Treasury, Mr David Gauke, confirmed that the Organisation for Economic Cooperation and Development (OECD) has adopted all of the proposals...
Phase I study evaluating safety and tolerability of VXM01 in pancreatic cancer...
4 December 2014 | By GlobalData
The first biologic to treat atopic dermatitis, Sanofi and Regeneron’s dupilumab, could launch in the US by Q2 2017, and the potentially game-changing drug could achieve annual sales of over $1.3 billion in this market by 2022, according to an analyst with research and consulting firm GlobalData.
4 December 2014 | By Santen
Following the launch of Santen in Italy in October 2014, Santen Italy s.r.l (Milano, Italy) (Santen) announces that Paolo Casati has been named General Manager of Santen Italy, effective November 21st, 2014...
4 December 2014 | By Bioquell
Norovirus season is upon us and Bioquell has issued tools to help combat the spread...
4 December 2014 | By Bristol-Myers Squibb Foundation
The Bristol-Myers Squibb Foundation announced nine new grants totaling more than $3.5 million to strengthen efforts in China and India in the fight against hepatitis B virus (HBV) and hepatitis C virus (HCV) infection by focusing on the most vulnerable, high-risk patient populations...
3 December 2014 | By Sagentia
Sagentia, a global science, product and technology development company, announced today that it is working with Chrono Therapeutics on the development of SmartStop™, the world’s first programmable and wearable nicotine delivery device to help people quit smoking...
3 December 2014 | By GlobalData
The Age-related Macular Degeneration treatment market across seven major countries (the US, UK, Germany, France, Spain, Italy and Japan) will almost double in value from $5.1 billion in 2013 to $10.1 billion by 2023, according to research and consulting firm GlobalData.
3 December 2014 | By Prothena
Prothena initiates NEOD001 global Phase 3 registrational trial based on positive results in ongoing phase 1/2 study of NEOD001 in Patients With AL Amyloidosis...
2 December 2014 | By Roche
Victory for patients as NICE accepts Gazyvaro™ (obinutuzumab) for treatment of most common adult leukaemia1...
2 December 2014 | By The Republic of Sierra Leone
The Chief Medical Officer of the Ministry of Health and Sanitation, Dr Brima Kargbo, will host an online press conference on Wednesday, December 3rd, 2014 at 15 GMT...
2 December 2014 | By Distributed by APO (African Press Organization) on behalf of #TackleEbola
The multimedia campaign is the first to directly engage Ebola survivors in delivering key protective messages...
2 December 2014 | By Inventiva
This follows an earlier positive opinion for IVA337 in October regarding the treatment of Systemic Sclerosis (SSc)...
2 December 2014 | By Exco InTouch
Exco InTouch, the leading provider of digital patient engagement and data capture solutions for clinical research and healthcare providers, will speak in two mHealth Solutions sessions focused on disease management at the annual mHealth Summit on Monday, 8th and Tuesday 9th December 2014...
